sector
Connection Days prepare the sector for the final HCG funding round
July 13, 2026

Three events. Three regions. Dozens of new connections. One shared ambition: investing in the talent and collaboration needed to advance the Dutch pharmaceutical sector. Over the past week, PharmaNL’s Human Capital Growth (HCG) Connection Days brought together professionals from across the pharmaceutical ecosystem in Oss (1 July), Groningen (7 July) and Leiden (9 July). Brigitte […]

bacteriofagen
A New Generation of Infection Control: PharmaNL Project INFECTORY Builds Dutch GMP Infrastructure for Bacteriophages
July 9, 2026

Antimicrobial resistance is a growing global challenge. Physicians are increasingly confronted with infections that no longer respond to existing antibiotics, while the development of new antibiotics continues to lag behind. A newly awarded Shared Development Infrastructure (SDI) project within PharmaNL aims to take an important next step by establishing a Dutch GMP production environment for […]

RiboFlux Develops Open Infrastructure for xRNA Production
June 18, 2026

In the recent spring 2026 funding round, ZonMw awarded grants to four projects within PharmaNL’s Shared Development Infrastructure (SDI) programme. The programme aims to strengthen the Dutch pharmaceutical sector through open, shared R&D infrastructure that accelerates and streamlines drug development. One of the selected projects is RiboFlux: a new platform for scalable and controlled xRNA […]

IgA
IgA as a Gamechanger: PHARMIGA Explores a New Generation of Antibodies
June 9, 2026

In the most recent funding round of the Shared Development Infrastructure (SDI) programme of PharmaNL, the project PHARMIGA has been awarded. The initiative taps into the largely untapped potential of antibodies, key components of the human immune system. Professor of Chemistry and Pharmaceutical Sciences Albert Heck (Utrecht University), an expert in biomolecular mass spectrometry and […]

vier nieuwe projecten
Advance Notice: New Human Capital Growth Funding Round 2026
June 4, 2026

Good news: a new funding call is on the horizon. ZonMw is expected to open a funding call under the PharmaNL Human Capital Growth (HCG) programme line on 23 June 2026. This programme line aims to support the development of a coherent, strengthened, and hybrid lifelong learning ecosystem for the pharmaceutical sector at post-secondary vocational […]

stamcel- en gentherapie
Bridging the Gap: new PharmaNL project strengthens continuing education in stem cell and gene therapy
May 28, 2026

“The cell and gene therapy field is evolving so rapidly that it is almost impossible for professionals to always stay up to date,” says Niels Geijsen, Head of the Department of Anatomy and Embryology at the Leiden University Medical Center (LUMC). With the newly awarded project Bridging the Gap, one of six projects funded in […]

PharmaNL Community Event brings the Dutch pharmaceutical sector together in Utrecht
May 21, 2026

With more than 80 participants from across the Dutch pharmaceutical innovation ecosystem, the PharmaNL Community Event on Wednesday, 20 May focused on connection, knowledge sharing, and shared ambition. Held at the Jaarbeurs in Utrecht, the event brought together researchers, educational institutions, companies, startups, and policymakers to reflect on the first results of PharmaNL and to […]

fermentation and bioprocessing
New education programmes in fermentation and bioprocessing strengthen the Dutch pharma ecosystem
May 7, 2026

“Those who don’t understand the latest technologies risk losing the competitive position of the Dutch pharmaceutical value chain,” warns Sven Stielstra, manager LIFE Capital at the LIFE Cooperative and project lead of the new PharmaNL initiative Fermentation and Bioprocessing for Smart and Sustainable Pharma. This project, launched at the beginning of 2026 within PharmaNL’s Human […]

IMED
IMED: filling the gap in molecular imaging education
April 23, 2026

“There is simply no structured education in molecular imaging to support drug development,” says internist-oncologist Derk Jan de Groot of the UMCG. With the new IMED (IMaging EDucation) project, UMCG, together with project partners Hanze and the LIFE Cooperative, aims to change that. The project, recently awarded within PharmaNL’s Human Capital Growth programme and made […]

Miranda van Eck
“Collaboration is key.” New board member Miranda van Eck on knowledge sharing and innovation in the pharmaceutical sector
April 20, 2026

At the beginning of this year, Miranda van Eck joined the board of PharmaNL as a new board member. Van Eck is Professor of Cardiovascular and Metabolic Therapies at Leiden University. Since September 2024, she has also been Scientific Director of the Leiden Academic Center for Drug Research, where she leads one of the eight […]